Quest Capital Management’s AbbVie ABBV Stock Holding History

Quest Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$479K	Sell	3,534 -1	-0%	-$118	0.08%	160
2021 Q3	$381K	Buy	3,535 +872	+33%	+$99.6K	0.07%	169
2021 Q2	$300K	Buy	2,663 +202	+8%	+$22.8K	0.06%	212
2021 Q1	$266K	Buy	2,461 +420	+21%	+$44.9K	0.06%	216
2020 Q4	$219K	Buy	+2,041	New	+$196K	0.05%	231
2019 Q2	–	Sell	-18,698	Closed	-$1.5M	–	220
2019 Q1	$1.5M	Buy	18,698 +7,087	+61%	+$580K	0.38%	42
2018 Q4	$1.07M	Buy	+11,611	New	+$1.02M	0.31%	46

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Quest Capital Management's ABBV Position: Q4 2021 in Review

Quest Capital Management reduced its AbbVie (ABBV) stake by 0.03% in Q4 2021, selling an estimated $118 and leaving 3,534 shares worth $479K. The position accounts for 0.08% of the portfolio, ranked #160.

Quest Capital Management first reported a position in ABBV in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.5M in Q1 2019. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Quest Capital Management held 3,534 shares of AbbVie worth $479K as of Q4 2021.
Quest Capital Management sold 1 AbbVie share in Q4 2021, an estimated $118.
AbbVie made up 0.08% of Quest Capital Management's portfolio in Q4 2021, its #160 holding.
Quest Capital Management first reported a position in AbbVie in Q4 2018 and has held it in 7 quarters since.
Quest Capital Management's AbbVie position peaked at $1.5M in Q1 2019.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.